Table 3.
Participant characteristics at baseline of included trials, N=6.
| Age (mean years) |
Gender (male/female) |
Type 1 diabetes | Type 2 diabetes | Duration of diabetes (mean years) |
HbA1ca
(mean %) |
BMIb (mean kg2) |
|
| Fioravanti [46] N=51c |
48.0d | 36/15d | 29d | 22d | 20.0d | 7.9d | 25.7d |
| Kim [47] N=70e |
52.8 | 40/30 | 0 | 70 | 11.8 | 7.7 | 25.0 |
| Logan [48] N=110 |
62.9 | 61/49 | NAf | NA | NA | 7.4 | 30.9 |
| Takenga [49] N=40 |
53.3 | 29/11 | NA | NA | NA | 8.6 | NA |
| Waki [50] N=54 |
57.2 | 41/13 | 0 | 54 | 9.0 | 7.0 | 26.7 |
| Zhou [51] N=100 |
54.2 | 57/43 | 18 | 82 | 6.6 | 9.8 | 23.0 |
aHbA1c: hemoglobin A1c.
bBMI: body mass index.
cIncluded N=54, numbers given for N=51 completers.
dProvided upon request.
eIncluded N=73, numbers given for N=70 completers.
fNA: not available.